13F filer · CIK 1009207 ↗
D. E. Shaw
You are looking at Q1 2019. See the latest, Q2 2026 →
Reported value
$77.39B
+6.6% on the quarter before
Positions
3,549
473 new · 644 sold out
Top 10
9.0%
of the value
Est. gain
+$5.90B
on stocks held all quarter
Est. return
+15.0%
on those stocks since Q4 2018
Positions as of Mar 31, 2019, from D. E. Shaw's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 17% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2018. Striped tiles are options.
Largest buys
Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Pfizer Inc~$438.7MAdded · 0.0% → 0.6%+10,328,490 shares
- Abbvie Inc~$401.3MAdded · 0.1% → 0.6%+4,979,335 shares
- Johnson & Johnson~$307.7MAdded · 0.2% → 0.6%+2,201,273 shares
- Gilead Sciences Inc~$261.0MAdded · 0.2% → 0.5%+4,014,025 shares
- MercadoLibre~$259.4MAdded · 0.1% → 0.4%+510,905 shares
- Starbucks Corp~$248.9MAdded · 0.1% → 0.4%+3,347,623 shares
- Walt Disney Company (The)~$221.1MAdded · 0.1% → 0.4%+1,991,745 shares
- Qualcomm~$212.0MAdded · 0.6% → 0.9%+3,717,214 shares
- Amgen Inc~$210.5MAdded · 0.1% → 0.4%+1,107,989 shares
- Conocophillips~$209.9MAdded · 0.2% → 0.5%+3,144,824 shares
Largest sells
Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Booking Hldgs Inc~$391.0MCut · 0.9% → 0.4%−224,079 shares
- Bristol Myers Squibb Co~$389.6MCut · 0.9% → 0.2%−8,166,049 shares
- NetflixPUT~$315.0MCut · 0.5% → 0.3%−883,500 underlying
- Citigroup Inc~$314.9MCut · 0.7% → 0.4%−5,061,722 shares
- PayPal~$281.9MCut · 0.5% → 0.2%−2,714,575 shares
- Shire Plc~$275.7MSold out · 0.4% → 0.0%−1,584,224 shares
- S&P Global Inc~$264.1MCut · 0.5% → 0.3%−1,254,387 shares
- United Technologies Corp~$247.7MCut · 0.3% → 0.1%−1,921,580 shares
- Nxp Semiconductors N V~$245.1MCut · 0.7% → 0.5%−2,773,099 shares
- Vmware Inc~$237.0MCut · 0.4% → 0.2%−1,312,674 shares
Holdings
As of Mar 31, 2019. Changes are in shares against Dec 31, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +11% · price +20.4% | 1.4% | $1.11B | +$169.3M | ||||||||
| Lowes Cos IncCOM · shares −1.5% · price +18.5% | 1.2% | $954.8M | +$149.2M | ||||||||
| MetaCL A · shares −13% · price +27.2% | 1.0% | $793.1M | +$169.4M | ||||||||
| Celgene CorpCOM · shares +3.6% · price +47.2% | 0.90% | $693.2M | +$214.4M | ||||||||
| QualcommCOM · shares +47% · price +0.2% | 0.86% | $667.8M | +$959,237 | ||||||||
| AmazonPUTCOM · shares −25% | 0.80% | $618.8M | — | ||||||||
| Verisign IncCOM · shares −9.3% · price +22.4% | 0.76% | $587.6M | +$107.7M | ||||||||
| Colgate Palmolive CoCOM · shares +9.9% · price +15.2% | 0.70% | $539.9M | +$64.7M | ||||||||
| Merck & Co IncCOM · shares +15% · price +8.8% | 0.64% | $496.2M | +$35.0M | ||||||||
| Abbvie IncCOM · shares +446% · price −12.6% | 0.63% | $491.2M | −$12.9M | ||||||||
| Ebay IncCOM · shares −0.5% · price +32.3% | 0.62% | $480.6M | +$117.4M | ||||||||
| Johnson & JohnsonCOM · shares +191% · price +8.3% | 0.61% | $469.0M | +$12.4M | ||||||||
| OracleCOM · shares −25% · price +19.0% | 0.60% | $467.5M | +$74.5M | ||||||||
| Pfizer IncCOM · shares +1,972% · price −2.7% | 0.60% | $460.9M | −$618,419 | ||||||||
| Fidelity Natl Information SvCOM · shares +46% · price +10.3% | 0.59% | $453.0M | +$28.9M | ||||||||
| MicrosoftCOM · shares −13% · price +16.1% | 0.58% | $446.2M | +$61.9M | ||||||||
| Activision Blizzard IncCOM · shares +87% · price −2.2% | 0.56% | $436.1M | −$5.3M | ||||||||
| AmazonCOM · shares +31% · price +18.6% | 0.56% | $435.8M | +$52.1M | ||||||||
| Wayfair IncCL A · shares +60% · price +64.8% | 0.56% | $430.1M | +$105.8M | ||||||||
| AlibabaSPONSORED ADS · shares −24% · price +33.1% | 0.55% | $424.7M | +$105.6M | ||||||||
| Gilead Sciences IncCOM · shares +168% · price +3.9% | 0.54% | $416.2M | +$5.9M | ||||||||
| ConocophillipsCOM · shares +109% · price +7.0% | 0.52% | $403.2M | +$12.7M | ||||||||
| Medtronic PlcSHS · shares +105% · price +0.1% | 0.52% | $401.3M | +$257,835 | ||||||||
| Nxp Semiconductors N VCOM · shares −38% · price +20.6% | 0.51% | $394.1M | +$67.4M | ||||||||
| BlockCL A · shares +124% · price +33.6% | 0.48% | $373.6M | +$42.0M | ||||||||
| Total · 3,549 positions | 100% | $77.39B | +$5.90B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2018 to Q1 2019: 2,186 stocks held throughout, up $5.90B (+15.0%).
- Celgene Corp+$214.4M+47%
- Meta+$169.4M+27%
- Apple+$169.3M+20%
- Lowes Cos Inc+$149.2M+19%
- Ebay Inc+$117.4M+32%
- Kraft Heinz Co−$25.5M−24%
- Biogen Inc−$25.6M−21%
- Cigna Corp New−$34.7M−15%
- Herbalife Nutrition Ltd−$35.8M−10%
- Pg&E Corp−$45.2M−25%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 12 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $210.20B+26% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $166.31B−9% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $182.42B+3% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $177.16B+26% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $141.06B+26% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $112.35B−18% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $136.27B+17% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $116.49B+9% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $106.92B−8% | SEC ↗ |
| Q1 2024 | May 15, 2024 (amended) | $116.85B+2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 (amended) | $114.44B+19% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $95.78B−2% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $97.90B+5% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $93.41B+3% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $90.48B+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $83.73B−2% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $85.30B−20% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $106.83B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $120.60B+9% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $110.81B−4% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $115.86B+12% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $103.59B−7% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $111.85B+14% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $97.71B+16% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $83.95B+31% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $64.09B−27% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $87.45B+8% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $81.21B+1% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $80.19B+4% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $77.39B+7% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $72.58B−13% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $83.24B+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $76.66B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $73.46B+1% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $72.62B+12% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $65.09B+8% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $60.46B+6% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $56.89B−3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $58.87B+4% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $56.68B+5% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $54.23B−3% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $55.73B | SEC ↗ |